Merck (MRK) Raw Materials (2009 - 2012)
Merck (MRK) posted quarterly Raw Materials of $265.0 million for Q2 2012, down 95.61% year-over-year from $6.0 billion in Q3 2011, and down 14.52% quarter-over-quarter from $310.0 million in Q1 2012.
Merck (MRK) Raw Materials (2009 - 2012) Analysis & Trends
Merck (MRK) has reported Raw Materials for 4 consecutive years, with $265.0 million the latest figure, recorded in Q2 2012.
- In Q2 2012, Raw Materials fell 95.61% year-over-year to $265.0 million; the TTM figure through Jun 2012 stood at $265.0 million (down 95.61% YoY), while the FY2011 annual figure was $297.0 million, down 5.71% from the prior year.
- Raw Materials fell to $265.0 million in Q2 2012 per MRK's latest filing, from $310.0 million in the prior quarter.
- Across five years, Raw Materials topped out at $6.0 billion in Q2 2011 and bottomed at $265.0 million in Q2 2012.
- Historically, Raw Materials has averaged $1.9 billion across 4 years, with a median of $312.5 million in 2010.
- Annual changes were most pronounced in 2011 — Raw Materials soared 1857.2% — and 2012, when it tumbled 95.61%.
- Merck's Raw Materials stood at $323.0 million in 2009, then dropped by 2.48% to $315.0 million in 2010, then declined by 5.71% to $297.0 million in 2011, then declined by 10.77% to $265.0 million in 2012.
- Business Quant data shows MRK's Raw Materials at $265.0 million in Q2 2012, $310.0 million in Q1 2012, and $297.0 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 265.00 Mn |
| Mar 31, 2012 | 310.00 Mn |
| Dec 31, 2011 | 297.00 Mn |
| Sep 30, 2011 | 5.80 Bn |
| Jun 30, 2011 | 6.04 Bn |
| Mar 31, 2011 | 306.00 Mn |
| Dec 31, 2010 | 315.00 Mn |
| Sep 30, 2010 | 5.44 Bn |
| Jun 30, 2010 | 308.40 Mn |
| Dec 31, 2009 | 323.00 Mn |